The Bristol Myers Squibb-Pfizer Alliance today announced a new direct-to-patient option for purchasing Eliquis (apixaban) via ...

The US Food and Drug Administration (FDA) announced the approval of 127 innovator and biosimilar drugs in 2024, a notable ...

A major collaboration between the Allen Institute and the Aligning Science Across Parkinson’s (ASAP) initiative is set to ...

French biotech One Biosciences has raised 15 million euros ($16 million) in series A financing to advance development of its ...

French ophthalmology company Nicox (EPA: ALCOX) has signed an agreement with Japan’s Kowa Company (TYO: 7807).

Spanish plasma-derived medicines specialist Grifols saw its share close up 7% yesterday, after it revealed that it will ...

South Korea’s Samsung Bioepis today announced it has entered into a license, development and commercialization agreement (DCA ...

US companies SandboxAQ and iOncologi have announced a strategic collaboration to jointly develop, validate, and commercialize ...

Artificial intelligence has edged past the pilot phase in clinical development. Once a niche add-on, AI is now helping ...

Sweden’s OncoZenge has announced an amendment to its license and supply agreement with Italian firm Molteni Farmaceutici.

Swiss pharma giant Roche has won approval from the UK’s Medicines and Healthcare Regulatory Agency (MHRA) for its combination ...

US rare disease meds developer Sarepta Therapeutics late yesterday announced a strategic restructuring plan designed to ...